The 2016 Annual Global Congress for ACOG featured new insights, lively debates, and more. Here's a sample of what the Contemporary OB/GYN staff overheard during the meeting.
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More